Author: Hu, Song; Jiang, Li-Bin; Zou, Xiao-Jing; Yi, Wei; Tian, De-Ying
Title: Hepatitis B virus upregulates host expression of a-1,2-mannosidases via the PPARa pathway Document date: 2016_11_21
ID: w5m23ikh_30
Snippet: In conclusion, the findings of the present study showed that HBV could increase the expression of class â… Î±-mannosidases both in vitro and in vivo. Moreover, the HBV envelope protein increases the Figure 5 ). These findings suggest that the class â… Î±-mannosidases could be used as drug targets to inhibit the demannosylation of HBV, thereby improving the binding of the virus to DC-SIGN and disrupting the immune tolerance to prevent and treat .....
Document: In conclusion, the findings of the present study showed that HBV could increase the expression of class â… Î±-mannosidases both in vitro and in vivo. Moreover, the HBV envelope protein increases the Figure 5 ). These findings suggest that the class â… Î±-mannosidases could be used as drug targets to inhibit the demannosylation of HBV, thereby improving the binding of the virus to DC-SIGN and disrupting the immune tolerance to prevent and treat viral infection.
Search related documents:
Co phrase search for related documents- â… Î± mannosidase and α mannosidase: 1, 2
- â… Î± mannosidase and viral infection: 1
- drug target and envelope protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- drug target and immune tolerance: 1
- drug target and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- drug target and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70
- drug target and viral infection treat: 1, 2, 3
- drug target and virus binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- envelope protein and HBV demannosylation: 1
- envelope protein and HBV envelope protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- envelope protein and α mannosidase: 1, 2
- envelope protein and immune tolerance: 1
- envelope protein and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- envelope protein and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- envelope protein and virus binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- HBV demannosylation and α mannosidase: 1, 2, 3, 4
- HBV demannosylation and immune tolerance: 1
- HBV demannosylation and present study: 1, 2
- HBV demannosylation and viral infection: 1, 2
Co phrase search for related documents, hyperlinks ordered by date